Dr. Bennani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St SW
Rochester, MN 55905Phone+1 507-284-2511
Education & Training
- Corewell Health East Beaumont (Royal Oak)Fellowship, Hematology and Medical Oncology, 2012 - 2015
- Cleveland Clinic Foundation/Fairview HospitalResidency, Internal Medicine, 2009 - 2012
- Mohammed V University Faculty of Medicine and PharmacyClass of 2001
Certifications & Licensure
- MN State Medical License 2015 - 2025
- MI State Medical License 2012 - 2016
- OH State Medical License 2009 - 2013
Clinical Trials
Publications & Presentations
PubMed
- 11 citationsDon't Put the CART Before the Horse: The Role of Radiation Therapy in Peri-CAR T-cell Therapy for Aggressive B-cell Non-Hodgkin Lymphoma.Omran Saifi, William G Breen, Scott C Lester, William G Rule, Bradley J Stish
International Journal of Radiation Oncology, Biology, Physics. 2023-08-01 - 2 citationsSirolimus as frontline therapy for-mutated histiocytic sarcoma.Karan L Chohan, Jithma P Abeykoon, Jason R Young, W Oliver Tobin, Mathew J Koster
Haematologica. 2023-06-01 - 11 citationsProcalcitonin as a biomarker for predicting bacterial infection in chimeric antigen receptor T-cell therapy recipients.Marissa Z Powell, Kristin C Mara, Radhika Bansal, Matthew A Hathcock, Arushi Khurana
Cancer Medicine. 2023-04-01
Journal Articles
- Genetic Subtyping of Breast Implant-Associated Anaplastic Large Cell LymphomaAndrew L Feldman, Garry S Brody, Rhett P Ketterling, N Nora Bennani, Mark W Clemens, Ellen D McPhail, Christin A Harless, David S Viswanatha, Rong He, Blood
Abstracts/Posters
- Characteristics, Treatment Patterns, and Outcomes in Primary Cutaneous Gamma Delta T Cell Lymphoma (PCGDTCL): A Real World Multi-Institutional Analysis of a Rare Malig...N. Nora Bennani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Peak Lymphocyte Count after CAR T Infusion Is a Clinically Accessible Test That Correlates with Clinical Response in Axicabtagene Ciloleucel Therapy for LymphomaN. Nora Bennani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Single-Agent Cladribine As an Effective Therapy for Adults with Langerhans Cell HistiocytosisNora N Bennani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Lectures
- Copanlisib in Combination with Nivolumab in Subjects with Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Primary Mediastinal Large B-Cell Lymphoma: A Phase 2 Study61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Axicabtagene Ciloleucel (Axi-cel) CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma: Real World ExperienceClinically Re...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Tumor Mutational Burden and Other Immunotherapy Markers in Histiocytic Neoplasms Using Next Generation Sequencing2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Professional Memberships
- Associate
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: